Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH grants anti-Notch-1 monoclonal antibody technology to Viragen

Oct. 3, 2000

Migration-inhibitory peptides identified and investigated at Kyowa Hakko

Oct. 2, 2000

Chugai examines novel enzyme inhibitors as potential anticancer agents

Oct. 2, 2000

Beacon describes preparation and activity of improved butyric acid esters

Oct. 2, 2000

New approach to oncolytic, skin disorders based on specific inhibition of 4-hydroxylase

Oct. 2, 2000

Sigma-Tau selects new camptothecin derivative for preclinical development

Oct. 2, 2000

Northwest's prostate cancer vaccine shows favorable progress in clinical trial

Oct. 2, 2000

3-D researchers patent alphav integrin inhibitors with broad indications

Sep. 29, 2000

Two-antigen combination melanoma vaccine enters phase I/II at MGH

Sep. 29, 2000

Results of marimastat/carboplatin combination trial in ovarian cancer disappointing

Sep. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....